The intersection of substance use with broader public health concerns.
Public health
The cardiovascular risks and benefits of quit smoking medicines
In this presentation, the speakers reported the results of a series of three population-based cohort studies relating to the use and effects of smoking cessation pharmacotherapies. The first of these studies provided evidence on how the...
Evento SONEPSYN / ISSUP Chile: Chemsex
Este lunes 11 de julio, a las 20:00 hrs. se realizará la reunión académica del Grupo de Trabajo de Adicciones de Sonepsyn, junto a ISSUP-Chile.
Alcohol Policy 19 Evidence to Action: Building a Framework for Change
The nation’s capital for the Alcohol Policy 19 Conference, convened by the U.S. Alcohol Policy Alliance will take place on September 14-16, 2022 Arlington, VA.
The 19th in a series of conferences on preventing and reducing alcohol-related problems using public policy strategies.
Costs of an Alcohol Measurement Intervention in Three Latin American Countries
Abstract Alcohol measurement in health care settings is an effective intervention for reducing alcohol-related harm. However, in many countries, costs related to alcohol measurement have not yet been transparently assessed, which may hinder...
Association of Prenatal Exposure to Maternal Drinking and Smoking With the Risk of Stillbirth
Abstract Importance Prenatal smoking is a known modifiable risk factor for stillbirth; however, the contribution of prenatal drinking or the combination of smoking and drinking is uncertain. Objective To examine whether prenatal exposure to...
New Psychoactive Substances (NPS) Webinar Series
Various NPS have significantly changed the picture of drug use in different countries. They are now very prominent in the drug market. Indeed, many of these substances are intended to circumvent drug laws and are sold as ‘legal’...
New Psychoactive Substances: What Are Synthetic Cannabinoids, Their Mechanisms of Action, and Health Risks?
Thursday, July 7, 2022 10:00 AM Eastern Time (Washington, DC time)
The presenters will discuss synthetic cannabinoids' action mechanisms and health risks in this webinar. Spanish - English interpretation will be available. No certificates of attendance will be offered.
Presenters
Highlights from the 2022 UNODC World Drug Report: Implications for drug prevention, treatment and care responses
ISSUP presented a webinar on Thursday, July 7, 2022, featuring Giovanna Campello, Chief of the Prevention, Treatment and Rehabilitation Section, United Nations Office on Drugs and Crime (UNODC) presenting highlights from the 2022 edition of...
The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis
Comorbid mental illnesses and substance use disorders are associated with adverse criminal, social, and health outcomes. Yet, their burden is not reliably known among prison populations. We therefore aimed to estimate the prevalence of comorbid serious mental illnesses and substance use disorders (dual disorders) among people in prison worldwide.